EVRYSDI POWDER FOR ORAL SOLUTION 0.75 MG/ML
Product details
Registration number: SIN16349P
Classification: Prescription Only
Active ingredients: Risdiplam
Strength: 60 mg
Dosage form: POWDER, FOR SOLUTION
Route: ORAL; ENTERAL
Registrant: ROCHE SINGAPORE PTE. LTD.
ATC code: M09AX10
HSA approval date: 20 October 2021
Manufacturer(s):
- F. Hoffmann-La Roche Ltd
- F. Hoffmann-La Roche Ltd.
Manufacturing country/countries: SWITZERLAND
What are the HSA registration number and classification for EVRYSDI POWDER FOR ORAL SOLUTION 0.75 MG/ML?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN16349P
Classification: Prescription Only
What active ingredients and strength are recorded for EVRYSDI POWDER FOR ORAL SOLUTION 0.75 MG/ML?
According to the HSA dataset updated 7 August 2026:
Active ingredients: Risdiplam
Strength: 60 mg
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for EVRYSDI POWDER FOR ORAL SOLUTION 0.75 MG/ML?
According to the HSA dataset updated 7 August 2026:
Dosage form: POWDER, FOR SOLUTION
Route: ORAL; ENTERAL
Who is the recorded registrant for EVRYSDI POWDER FOR ORAL SOLUTION 0.75 MG/ML?
According to the HSA dataset updated 7 August 2026:
Registrant: ROCHE SINGAPORE PTE. LTD.
Which manufacturers and countries are listed for EVRYSDI POWDER FOR ORAL SOLUTION 0.75 MG/ML?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s):
- F. Hoffmann-La Roche Ltd
- F. Hoffmann-La Roche Ltd.
Manufacturing country/countries: SWITZERLAND
Where can I look up EVRYSDI POWDER FOR ORAL SOLUTION 0.75 MG/ML in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN16349P or the exact product name EVRYSDI POWDER FOR ORAL SOLUTION 0.75 MG/ML. The general register link does not preselect this product.
What are the source dates for this EVRYSDI POWDER FOR ORAL SOLUTION 0.75 MG/ML record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this EVRYSDI POWDER FOR ORAL SOLUTION 0.75 MG/ML record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN16349P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)